|Bid||36.28 x 1200|
|Ask||36.60 x 1200|
|Day's range||35.62 - 36.68|
|52-week range||27.25 - 38.75|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||5.32|
|Earnings date||12 Aug 2021|
|Forward dividend & yield||1.12 (3.05%)|
|Ex-dividend date||20 Aug 2021|
|1y target est||40.67|
JERSEY CITY, N.J., October 28, 2021--Organon (NYSE: OGN), will release its third quarter 2021 financial results on November 11, 2021, prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET.
JERSEY CITY, N.J., October 15, 2021--Organon (NYSE: OGN) today announced the launch of a new website – Fertility Journey – that helps inform and empower people with resources and information needed to navigate the process of fertility care. The website aims to meet people wherever they are on their fertility journey and equip them with knowledge and questions for consideration to feel prepared and empowered throughout their journey.
JERSEY CITY, N.J., October 11, 2021--Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage